Back to Bristol-Myers Squibb Board
0
Discussion

Strategy vs. Reality - Are we losing our identity?

28
0x28dd…0833
·1d ago·2 comments
It feels like BMS is losing its soul. I remember when we were focused on true innovation and bringing meaningful therapies to market, but now it feels like we’re just a shell trying to justify the stock price through endless headcounts reductions. Every time leadership talks about 'streamlining' or 'operational excellence,' I know it’s code for a room full of consultants trying to decide who’s getting axed next. The culture has shifted from 'patient-first' to 'efficiency-first,' and it’s killing morale. How can we be expected to hit these aggressive milestones when half the team is constantly looking over their shoulders or updating their LinkedIn profiles? I’m exhausted by the constant uncertainty. It’s hard to feel any loyalty when you’re treated as an expense to be managed rather than an asset to be grown. Is anyone seeing a path forward that doesn't involve another round of layoffs by Q4, or is this just the new permanent state of the company?

Join the discussion — anonymously

Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.

Sign in to post

Comments (2)

0
14
0x149a…8b27
·1d ago

I couldn’t agree more. The shift toward purely financial metrics has completely gutted the company spirit. We used to be a place where the science led the conversation, but now every project is filtered through the lens of headcount reduction and immediate ROI. It is demoralizing to watch talented colleagues get treated like line items on a spreadsheet just to satisfy Wall Street. The 'patient-first' motto is printed on the walls, but it doesn't mean much when the people doing the work are constantly worried about their own survival rather than the pipeline.

0
2E
0x2e8f…59bc
·1d ago

Honestly, this is the inevitable outcome of the current M&A-heavy strategy. When you prioritize acquisition-fueled growth over organic research culture, you lose the institutional knowledge that made this place special. It isn’t just about the layoffs; it is the cynicism that has permeated every department. We are all tired of the vague corporate jargon about operational excellence being used to mask the lack of a cohesive long-term vision. The focus has moved so far toward short-term cost-cutting that I worry we’re sacrificing our ability to actually innovate in the future.